The inactivation approach presented in this technology provides for a safe, non-infectious composition for vaccination against the corresponding agent. More
Invention can be developed as an inhibitor therapeutically or prophylactically against retroviral and non-retroviral infections, and can be used in combination with other anti-viral agents to treat patients who have drug-resistant virus. More
All rights reserved. Terms and Conditions | Contact us
